Tilray (NASDAQ:TLRY) — the global cannabis producer reported a surprise profit in its latest earnings report — sending its stock up 3%. What’s the big deal? Cannabis stocks shot up in recent weeks after the House passed a bill to decriminalize cannabis. This is the second time the bill has passed the House. The first…
Read moreCannabis investors might have to wait longer for legalization
Patience is the name of the game for investors waiting for an all-clear from Uncle Sam on cannabis legalization. Cannabis stocks are down 60% since last February — while the S&P 500 is up nearly 15%. Hopes of legalization fell flat from Republican pushback and red tape. Could 2022 look different as support builds on…
Read moreCannabis stocks pop on new legalization attempts
What do most Americans want? Cannabis legalization — with an all-time high agreement from 60% of adults. Republican-led efforts to legalize cannabis has the industry on the move. While this isn’t an immediate path to legalization, it does have big implications… What’s the big deal? The cannabis industry has been on a downwards spiral since…
Read moreCannabis stocks moves up on regulatory actions
Cannabis veterans are pounding the pavement with the “generational wealth opportunity” in US cannabis stocks. But 2021 wasn’t an easy year for this sector to ride out. Compared to seeing triple-digit gains in 2020, many cannabis stocks are down 30% plus. Last Friday, it was revealed that Republicans are expected to introduce a cannabis reform…
Read moreUS cannabis stocks are undervalued but their future depends on legalization
Analysts see a “generational wealth opportunity” in cannabis stock — expecting a future of green returns — but all investors see is red. Last week, a bill to allow banks to do business with US cannabis companies made progress in the White House — giving hope to underperforming cannabis stocks. Where US investors get their…
Read moreCannabis stocks sees signs of life with banking regulation push
On Tuesday, the US House of Representatives approved a bill letting banks do business with cannabis companies — but whether it passes depends on the Senate. What’s the big deal? The cannabis industry did $20.3B in sales last year — which was mostly in cash. The bill passing would be a big deal for cannabis…
Read moreGrowGeneration stock: Should you take a puff on this hydroponic company?
Out of the concrete grew a rose. No soil needed. Share prices of GrowGeneration stock, a hydroponics company, is blooming while the rest of the basic materials industry wilts. Now, the company has raised its financial guidance after another successful quarter. GrowGeneration Stock: The future of crop growth Hydroponics (gardening without soil) is gaining popularity…
Read moreCannabis stocks on watch as legalization makes progress
A draft of the long-awaited Cannabis Administration and Opportunity Act is being released today — which could light up cannabis stocks. What’s the big deal? US Federal legalization of cannabis is on the horizon — and this is one move you won’t want to miss out on. With Biden in office and the Democrats controlling…
Read moreCuraleaf expands into the European market with the acquisition of Emmac Life Sciences
With cannabis legalization potentially coming to the US, investors won’t have to hide those sandwiches anymore. But one US company is looking beyond the US to take on the next big cannabis market — Europe. On Mar. 9, Curaleaf agreed to buy one of Europe’s largest cannabis operators, Emmac Life Sciences — sending Curaleaf’s stock…
Read moreCannabis stocks are lit — and the industry is looking to go higher with legalization
Everyone’s getting ready for US legalization of cannabis, including Ernie. On Feb. 9, two big announcements in the cannabis industry sent pot stocks higher: Tilray ($TLRY) announced a deal to supply medical cannabis in the UK — shares up 40%. Canopy Growth ($CGC) reported stronger than expected earnings and expects — shares up 13%. Go…
Read more